Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2017: 100.00 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2019) [Effective from January 1, 2019]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2019)
[Effective from January 1, 2019]
For more details click here

ICV 2017: 100.00
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2017: 100.00
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2017: 100.00
NAAS RATING 2018: 5.38

Int.J.Curr.Microbiol.App.Sci.2019.8(7): 2446-2456
DOI: https://doi.org/10.20546/ijcmas.2019.807.301


Seroprevalence of Hepatitis B Virus in Multitransfused Patients with Special Reference to Occult Hepatitis B Virus Infection
M. Paranjpe Supriya1, S. Supare Sundaram2*, Nataraj Gita1 and R. Mehta Preeti1
1Department of Microbiology, KEMH, Parel Mumbai, India 2Department of Microbiology, GMC, Nagpur, India
*Corresponding author
Abstract:

Hepatitis B virus (HBV) is one of the most important agent causing transfusion transmitted infections in multitranfused patients. HBV-DNA is a concern for transmission from transfusion or transplantation in serologically negative blood for HBV i.e., occult hepatitis B (OHB). The aim of this study is to find out the prevalence of HBV infection in multitransfusd patients including OHB infections. The present study was conducted in 200 multitransfused patients attending the haematology/thalassemia OPD. Blood sample were collected and tested for HBsAg, Anti HBs, Anti HBc and HBV DNA by DNA PCR. Out of the total 200 patients, total prevalence of HBV amounted to 28% including various markers of HBV infection was HBsAg only 3(1.5%), Anti HBc only 49(24.5%) and Anti HBc plus HBs Ag 4(2%). Out of 49 AntiHBc positive samples 3(6.12%) patients were positive for HBV DNA. Newer methods such as HBV DNA PCR, Anti HBc should be introduced in the routine screening of blood donors to reduce the window period and to prevent transmission. Emphasis on complete hepatitis B vaccination and regular follow up for anti HBs titre, providing booster doses for those in need should be implemented.


Keywords: Hepatitis B virus, Seroprevalence, Multitransfused patients
Download this article as Download

How to cite this article:

Paranjpe Supriya, M., S. Supare Sundaram, Nataraj Gita and Mehta Preeti, R. 2019. Seroprevalence of Hepatitis B Virus in Multitransfused Patients with Special Reference to Occult Hepatitis B Virus Infection.Int.J.Curr.Microbiol.App.Sci. 8(7): 2446-2456. doi: https://doi.org/10.20546/ijcmas.2019.807.301